Skip to main content
TG THERAPEUTICS, INC. logo

TG THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · TGTX ISIN · US88322Q1085 LEI · 529900X21UKABN9NJ529 US Manufacturing
Open in API
Filings indexed 1,012 across all filing types
Latest filing 2013-05-31 Capital/Financing Update
Country US United States of America
Listing US TGTX

About TG THERAPEUTICS, INC.

https://www.tgtherapeutics.com/

TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. The company's primary area of focus is autoimmune diseases, particularly multiple sclerosis (MS). Its lead commercial product is BRIUMVI® (ublituximab), an approved therapy for adults with relapsing forms of MS. TG Therapeutics also develops a pipeline of potential therapies for B-cell malignancies and other autoimmune conditions, including investigational CAR-T cell therapies.

Recent filings

Filing Released Lang Actions
FORM S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for sale to the public. It includes details about the offering, the company, and references to other SEC filings such as 10-K, 10-Q, and 8-K reports. This type of filing is related to capital raising activities and securities registration rather than financial reporting, management changes, or other categories. Therefore, it fits the Capital/Financing Update (CAP) category, which covers updates on company fundraising and financing activities.
2013-05-31 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2013-05-29 English
FORM 8-A12B
Regulatory Filings Classification · 95% confidence The document is a Form 8-A12B filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It describes the securities to be registered (common stock) and includes details about voting, dividend, liquidation rights, and signatures. This is a regulatory filing related to securities registration, not a financial report, earnings release, or management information. The document length is 3752 characters, which is relatively short and contains no financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2013-05-28 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The text specifically mentions the company announcing the approval of its common stock for listing on the NASDAQ Capital Market and the expected commencement of trading. The document includes a press release as an exhibit. The length is 2757 characters, which is relatively short and the content is an announcement of an event rather than a detailed financial report or earnings release. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2013-05-28 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2013
2013-05-14 English
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report under the Securities Exchange Act of 1934. It announces the issuance of a press release regarding the company's first quarter financial results for the period ended March 31, 2013, and mentions an upcoming investor conference call. The document itself does not contain detailed financial statements or substantive financial data but rather serves as an announcement of the earnings release and related events. The length is 2746 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as an Earnings Release (ER) announcement within a Form 8-K context, but since the document is the 8-K itself announcing the earnings release and not the earnings release document alone, the appropriate classification is ER with high confidence.
2013-05-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.